Zolivox™
Linezolid USP
Oxazolidinone (Other Antibacterials)
Indication:
It is indicated in adults and children for the treatment of the following infections caused by susceptible Gram-positive bacteria:
• Nosocomial pneumonia
• Community-acquired pneumonia
• Complicated skin and skin structure infections, including diabetic foot infections without concomitant osteomyelitis
• Uncomplicated skin and skin structure infections Vancomycin-resistant Enterococcus faecium infections.
Dosage & Administration:
| Infections | Pediatric | Adults & Adolescents | Duration of treatment |
| Nosocomial pneumonia | 10 mg/kg IV or oral every 8 hours | 600 mg IV or oral every 12 hours | 10-14 days |
| Community acquired pneumonia | |||
| Complicated skin and soft tissue infections | |||
| Vancomycin-resistant Enterococcus faecium infections, including concurrent bacteremia | 10 mg/kg IV or oral every 8 hours | 600 mg IV or oral every 12 hours | 14-28 days |
| Uncomplicated skin and soft tissue infections | <5 yrs: 10 mg/kg oral every 8 hours 5-11 yrs: 10 mg/kg oral every 12 hours | Adults: 400 mg oral every 12 hoursAdolescents: 600 mg oral every 12 hours | 10-14 days |
Preparation:
Zolivox™ 400 Tablet: Each box contains 1X10’s Tablet in Alu-Alu blister pack.
Zolivox™ 600 Tablet: Each box contains 1X10’s Tablet in Alu-Alu blister pack.
